linkedin-urn:li:ugcPost:7247621815441760256

Submitted by ryadav-admin on
Feed type
Linkedin
Post created date
1727967695
Post ID
urn:li:ugcPost:7247621815441760256

Introducing the AtriClip® FLEX-Mini™ device. The third-generation and latest addition to our AtriClip® family, it features a closed-ended design that's 60% smaller than the next lowest profile clip on the market – all while maintaining continual parallel closing pressure and stability that AtriClip devices are known for.​
​
Learn how the FLEX-Mini could elevate your practice: <a href="https://okt.to/nTWM6C&quot; target="_blank">https://okt.to/nTWM6C</a&gt;

Post video URL
https://dms.licdn.com/playlist/vid/v2/D5610AQHth7Yla9_sqg/mp4-720p-30fp-crf28/mp4-720p-30fp-crf28/0/1727967667836?e=1728831600&v=beta&t=PCuD3r-gc1GgZHKnZOt4ToQLH0GUgnraI-RDikr6io0
Post URL
https://www.linkedin.com/feed/update/urn:li:ugcPost:7247621815441760256
Post creted timestamp

linkedin-urn:li:share:7247349650762964993

Submitted by ryadav-admin on
Feed type
Linkedin
Post created date
1727902806
Post ID
urn:li:share:7247349650762964993

Patients with Inappropriate Sinus Tachycardia (IST) often experience symptoms that significantly impact their quality of life. For those who don’t respond to or are intolerant to medications, the HEAL-IST clinical trial is evaluating a new hybrid ablation procedure as a potential treatment.​
​
Learn more about the study: heal-ist.com​
​
<a href='https://www.linkedin.com/feed/hashtag/?keywords=ClinicalTrial&highlight…; target='_blank'>#ClinicalTrial</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=IST&highlightedUpdateUr…; target='_blank'>#IST</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=Innapropriatesinustachy…; target='_blank'>#Innapropriatesinustachycardia</a>​
​

Post image URL
https://media.licdn.com/dms/image/v2/D5610AQGBVv9fT89Jpw/image-shrink_800/image-shrink_800/0/1727902803534?e=1728691200&v=beta&t=2O6BIA1UH934S2JmghZ2dpw7OL68uRZahmZN5RIC8Ec
Post URL
https://www.linkedin.com/feed/update/urn:li:share:7247349650762964993
Post creted timestamp

Twitter-1841519781263921168

Submitted by ryadav-admin on
Feed type
Twitter-AtricureCEO
Post created date
2024-10-02
Post ID
1841519781263921168

Great start to the day at <a href="https://twitter.com/MSUMD&quot; target="_blank">@MSUMD</a>'s Grand Rounds, sharing insights on advances in AF treatment with a room full of doctors, pharmacists, residents, &amp; medical students. Also appreciated additional valuable conversations with <a href="https://twitter.com/CorewellHealth&quot; target="_blank">@CorewellHealth</a> surgeons about Afib &amp; cardiac surgery.

Post image URL
https://pbs.twimg.com/media/GY5WZIcWIAAtKer.jpg
Post URL
https://t.co/2TTJohSIrx
Post creted timestamp

Twitter-1841496547998978078

Submitted by ryadav-admin on
Feed type
Twitter
Post created date
2024-10-02
Post ID
1841496547998978078

In a retrospective analysis sponsored by AtriCure, healthcare systems saved an average of $8,601 in total healthcare costs for lobectomy patients who received Cryo Nerve Block (ablation) for post-op pain management compared to those who did not. ​

Learn more:… <a href="https://t.co/FljiwKEfuS&quot; target="_blank">https://t.co/FljiwKEfuS</a&gt;

Post image URL
https://pbs.twimg.com/media/GY5PWWBWMAAZpcF.jpg
Post URL
https://t.co/9vgsYgowuK
Post creted timestamp

linkedin-urn:li:share:7247259176400211968

Submitted by ryadav-admin on
Feed type
Linkedin
Post created date
1727881235
Post ID
urn:li:share:7247259176400211968

In a retrospective analysis sponsored by AtriCure, healthcare systems saved an average of $8,601 in total healthcare costs for lobectomy patients who received Cryo Nerve Block (ablation) for post-op pain management compared to those who did not. ​

Learn more about the device reducing hospital system costs and relieving post-op pain at: <a href="https://okt.to/auKl0L&quot; target="_blank">https://okt.to/auKl0L</a&gt;

Post image URL
https://media.licdn.com/dms/image/v2/D4D10AQHQVUIPWDa2KQ/image-shrink_1280/image-shrink_1280/0/1727881231090?e=1728666000&v=beta&t=gLZ5oPsOggcVbmbn-mXgrCadoOqE3tAn9yCvgjKYswg
Post URL
https://www.linkedin.com/feed/update/urn:li:share:7247259176400211968
Post creted timestamp

Twitter-1841131018494877816

Submitted by ryadav-admin on
Feed type
Twitter
Post created date
2024-10-01
Post ID
1841131018494877816

We're excited to share the Isolator® Synergy™ EnCompass® Clamp has received regulatory approval in CE-marked countries in Europe!

The EnCompass clamp provides a simpler and faster approach to ablating the heart in open-chest procedures.

Read the full release to learn more:… <a href="https://t.co/gouR2Xny4E&quot; target="_blank">https://t.co/gouR2Xny4E</a&gt;

Post image URL
https://pbs.twimg.com/media/GY0C2cSXsAI--Zo.png
Post URL
https://t.co/rzwRUbhjzA
Post creted timestamp

Twitter-1841135721198842173

Submitted by ryadav-admin on
Feed type
Twitter-AtricureCEO
Post created date
2024-10-01
Post ID
1841135721198842173

Over the past two years, the EnCompass Clamp has made a real impact in advancing treatment alongside cardiac surgery in the U.S. We're eager to bring this innovative therapy to patients &amp; physician partners in Europe, expanding our international line.

Post URL
https://t.co/arC75d0FUp
Post creted timestamp

linkedin-urn:li:share:7246897946720419842

Submitted by ryadav-admin on
Feed type
Linkedin
Post created date
1727795111
Post ID
urn:li:share:7246897946720419842

We're excited to share the Isolator® Synergy™ EnCompass® Clamp has received regulatory approval in CE-marked countries in Europe!

AtriCure’s portfolio of bipolar radiofrequency (RF) ablation devices have been used in over 575,000 cases, backed by continuous innovation, clinical science, and education. The EnCompass clamp is our latest RF device providing a simpler and faster approach to ablating the heart in open-chest procedure.

Read the full release to learn more: <a href="https://okt.to/Qntpc3&quot; target="_blank">https://okt.to/Qntpc3</a&gt;

Post image URL
https://media.licdn.com/dms/image/v2/D5610AQE_OOTfLToWXQ/image-shrink_800/image-shrink_800/0/1727795108503?e=1728651600&v=beta&t=zGNyOeuc_Em8NNccaGgOV_TEo297sJwZ-U5LBrovNDo
Post URL
https://www.linkedin.com/feed/update/urn:li:share:7246897946720419842
Post creted timestamp

Twitter-1840542098296123519

Submitted by ryadav-admin on
Feed type
Twitter
Post created date
2024-09-29
Post ID
1840542098296123519

What an enriching experience over the past few days with the discussions and insights from physicians globally. As <a href="https://twitter.com/hashtag/APHRS2024?src=hashtag_click&quot; target="_blank">#APHRS2024</a> comes to a close, the AtriCure Asia-Pacific team would like to thank you all for your engagement and collaboration. See you all next year at APHRS 2025!

Post image URL
https://pbs.twimg.com/media/GYrrSJzXsAEyi-Y.jpg
Post URL
https://t.co/5WqzmYwaI3
Post creted timestamp

linkedin-urn:li:share:7246307788086280192

Submitted by ryadav-admin on
Feed type
Linkedin
Post created date
1727654406
Post ID
urn:li:share:7246307788086280192

What an enriching experience over the past few days with the discussions and insights from physicians globally. As <a href='https://www.linkedin.com/feed/hashtag/?keywords=APHRS2024&highlightedUp…; target='_blank'>#APHRS2024</a> comes to a close, the AtriCure Asia-Pacific team would like to thank you all for your engagement and collaboration. See you all next year at APHRS 2025! ​
<a href='https://www.linkedin.com/feed/hashtag/?keywords=APHRS2024&highlightedUp…; target='_blank'>#APHRS2024</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=HybridAFTherapy&highlig…; target='_blank'>#HybridAFTherapy</a>​

Post image URL
https://media.licdn.com/dms/image/v2/D5610AQEJ7ugjrxI7-g/image-shrink_800/image-shrink_800/0/1727654405086?e=1728604800&v=beta&t=jqNLwFqXKN8TB1M86CGz2HbuEisCG_LCm7bjrqtj26s
Post URL
https://www.linkedin.com/feed/update/urn:li:share:7246307788086280192
Post creted timestamp
Subscribe to
© 2025 Atricure, Inc. All Rights Reserved.